Health Canada Clears Cutera’s AviClear™
The First and Only Device in North America Cleared for the Treatment of Mild, Moderate and Severe Acne
AviClear has been Proven Safe and Effective Through an Extensive Clinical Trial
Provides Long-term Resolution of Acne Across All Skin Types
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220713005256/en/
AviClear Console (Photo: Business Wire)
AviClear is a laser treatment that offers a safe, effective, prescription-free solution for acne. In addition to reducing existing acne, clinical trials show that future breakout episodes are shorter, less intense, and more infrequent following three 30-minute treatment sessions. Further, acne clearance results continue to improve over time, demonstrating the long-term efficacy of this novel treatment. Importantly, no pain mitigation was utilized or required by any clinical study participant.1
Acne vulgaris is a nearly universal skin disease, with approximately 50 million North American teens and young adults seeking treatment each year.2 AviClear’s 1726nm wavelength treats acne at the source by selectively targeting the sebocytes and suppressing sebum production. Overproduction of sebum by the sebaceous glands is one of the leading causes of acne.3
“Acne affects so many people – from teens to women in menopause, and everyone in between,” said
“We are ecstatic with AviClear’s expansion into the Canadian market as an innovative tool for dermatologists and as a treatment that inspires hope for acne patients,” said
Canadian doctors and consumers are encouraged to visit www.AviClear.com and sign up for updates on product availability and local treatment providers.
Data on file, FDA clearance study.
- O’Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome 2018;6: 177.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005256/en/